n-methylaspartate has been researched along with simvastatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alberch, J; Canals, JM; del Toro, D; Humbert, S; Pol, A; Saudou, F; Xifró, X | 1 |
| Herron, CE; Hughes, B; Métais, C | 1 |
| Fan, H; Huang, J; Lai, X; Liu, A; Qiao, L; Shen, M; Wu, J; Yan, J | 1 |
3 other study(ies) available for n-methylaspartate and simvastatin
| Article | Year |
|---|---|
Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease.
Topics: Animals; Anticholesteremic Agents; beta-Cyclodextrins; Brain; Caveolin 1; Cell Membrane; Cell Survival; Cells, Cultured; Cholesterol; DNA; Excitatory Amino Acid Agonists; Fluorescent Antibody Technique; Homeostasis; Humans; Huntingtin Protein; Huntington Disease; Indicators and Reagents; Membrane Microdomains; Mice; Mice, Transgenic; N-Methylaspartate; Neostriatum; Nerve Tissue Proteins; Nuclear Proteins; Simvastatin; Transfection; Triglycerides | 2010 |
Simvastatin increases excitability in the hippocampus via a PI3 kinase-dependent mechanism.
Topics: Action Potentials; Animal Feed; Animals; Chromones; Electric Stimulation; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Female; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Long-Term Potentiation; Male; Mice, Inbred C57BL; Microelectrodes; Morpholines; N-Methylaspartate; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Simvastatin; Tissue Culture Techniques | 2015 |
Simvastatin Improves Behavioral Disorders and Hippocampal Inflammatory Reaction by NMDA-Mediated Anti-inflammatory Function in MPTP-Treated Mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Dopaminergic Neurons; Hippocampus; Inflammation; Mice, Inbred C57BL; N-Methylaspartate; Neuroprotective Agents; Parkinson Disease; Simvastatin | 2020 |